Shopping Cart
Remove All
Your shopping cart is currently empty
Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor, showing IC50 values of 3.7 nM for ROCK-I and 2.3 nM for ROCK-II, and capable of lowering intraocular pressure (IOP) without inducing hyperemia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,900 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,480 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,890 | 8-10 weeks | 8-10 weeks |
| Description | Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor, showing IC50 values of 3.7 nM for ROCK-I and 2.3 nM for ROCK-II, and capable of lowering intraocular pressure (IOP) without inducing hyperemia. |
| Targets&IC50 | ROCKI:3.7 nM, ROCKII:2.3 nM |
| In vitro | Sovesudil (PHP-201) at a concentration of 1 μM, when administered for 60 minutes, can induce changes in the behavior of human trabecular meshwork (HTM) cells [1]. |
| In vivo | Sovesudil, at concentrations of 0.1%, 0.3%, and 0.5%, administered to male New Zealand White rabbits, effectively lowers Intraocular Pressure (IOP) in both normotensive and acute hypertensive conditions without inducing significant hyperemia [1]. |
| Molecular Weight | 407.44 |
| Formula | C23H22FN3O3 |
| Cas No. | 1333400-14-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.